About THERABENE INC.
Therabene is a biotechnology company focused on developing PROTAC degraders to target cancers, viral infections, and autoimmune diseases. The company uses a novel approach by eliminating disease-causing proteins rather than just inhibiting them.
Design and development of PROTAC degradersUse of virtual screening and generative AI tools in drug discoveryTargeting of undruggable proteins such as CDK9 and c-MycCollaboration with academic and clinical research institutions and pharmaceutical companies
Is this your company?
Claim this profile to keep it accurate — and see the federal & state opportunities GovIntel's AI has matched to THERABENE INC. right now.
Claim this profile See matched opportunitiesData compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate? Let us know.